Santen Pharmaceutical VP of Finance Salary | Comparably
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products read more
EMPLOYEE
PARTICIPANTS
12
TOTAL
RATINGS
132

Santen Pharmaceutical VP of Finance Salary

The average Santen Pharmaceutical VP of Finance earns an estimated $165,606 annually. Santen Pharmaceutical's VP of Finance compensation is $40,924 less than the US average for a VP of Finance.

The Finance Department at Santen Pharmaceutical earns $7,654 more on average than the Customer Support Department.

Last updated 4 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$165,606
Average Compensation
$165,606
avg. base

VP of Finance Salaries at Santen Pharmaceutical

VPs of Finance earn $21,390 more than Accounting Managers.

Accounting Manager
$144k*
Financial Analyst
$107k*
Senior Accountant
$103k*
Business Analyst
$100k*
Accountant
$83k*
* estimated salary

Compensation at Santen Pharmaceutical by Department

The Finance Department averages $7,654 more than the Customer Support Department, and $10,164 less than the Marketing Department

Marketing
$107,698 Avg. total comp.
+$10k
Finance
$97,534 Avg. total comp.
Customer Support
$89,880 Avg. total comp.
-$8k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to Santen Pharmaceutical reported making $231,000, while the average male VP of Finance at similar sized companies reported making $214,467.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to Santen Pharmaceutical reported making $223,611, while the average Asian or Pacific Islander VP of Finance at similar sized companies reported making $176,500.

How VPs of Finance at Santen Pharmaceutical Rate Their Compensation

The majority of VPs of Finance at Santen Pharmaceutical believe they're not compensated fairly. 50% of VPs of Finance at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical

×
Rate your company